Macquarie Group’s KALA BIO KALA Stock Holding History

Macquarie Group’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8	Closed	-$51K	–	2627
2021 Q3	$51K	Buy	+8	New	+$69K	﹤0.01%	2230

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAFP

Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group's KALA Position: Q4 2021 in Review

Macquarie Group sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 8 shares — an estimated $51K sold.

Macquarie Group first reported a position in KALA in Q3 2021 and held it in 1 quarter. The position peaked at $51K in Q3 2021. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

Macquarie Group reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
Macquarie Group sold 8 KALA BIO shares in Q4 2021, an estimated $51K.
Macquarie Group first reported a position in KALA BIO in Q3 2021 and held it in 1 quarter.
Macquarie Group's KALA BIO position peaked at $51K in Q3 2021.
79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.